Search results
AstraZeneca Pulls Out Its COVID-19 Vaccine From Global Markets After Court Docs Shows Side Effects -...
EconoTimes· 2 days agoAstraZeneca plc, a British-Swedish pharmaceutical and biotechnology company, is reportedly...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 2 hours agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 2 days agoAstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 2 hours agoUnder the terms of the agreement, Sanofi will begin to book sales of Novavax’s COVID-19 vaccine...
AstraZeneca pulls COVID-19 vaccine from global markets
UPI· 2 days agoAstraZeneca Wednesday said it was pulling its Vaxzevria COVID-19 vaccine pictured here from sale...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 2 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
...Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop...
CBS 47 Fresno· 10 hours agoThe terms of the agreement include: a co-exclusive license to co-commercialize Novavax's current stand-alone adjuvanted COVID-19 vaccine
Wednesday's Health Report: Astrazeneca pulling COVID-19 vaccine, cites low demand
WBRZ 2 Baton Rouge· 3 hours agoBATON ROUGE — U.K.-based drug manufacturer Astrazeneca is pulling its COVID-19 vaccine globally. They cited low demand. The company said ...
French, US drug firms team up for Covid-flu shot
Medical Xpress· 3 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialize Novavax's COVID-19 vaccine worldwide, except in ...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 8 minutes agoNovavax shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement...